Product Features

[Product features]

1. Selected Strains with High Antigenicity
The vaccine utilizes the meticulously cloned and screened Newcastle disease strain La Sota and the avian influenza subtype H9 strain SS, providing effective cross-protection against prevalent subtype H9 avian influenza and Newcastle disease virus strains across the country.

2. High Viral Titer and Superior Antibody Response
Advanced antigen ultrafiltration and concentration technology ensures highly purified antigens, resulting in excellent antibody uniformity, high antibody levels, and prolonged duration of immunity.

3. Advanced Process Ensures Product Stability
The application of advanced equipment and processes such as centrifugation and filtration ensures low residual endotoxin (≤50 EU/ml), total protein content (≤1mg/ml), and formaldehyde content (≤0.02%, only one-tenth of the Chinese standard). The vaccine exhibits uniform particle size, low viscosity, and high stability.

4. High-Quality Adjuvant with Minimal Stress
Imported food-grade adjuvants and raw materials are used to minimize immunization stress, promote rapid absorption, and ensure safer injection.

[Ingredients]

The vaccine is composed of inactivated NDV and AIV (subtype H9).

The virus concentration before inactivation: NDV ≥ 10^8.0EID₅₀ /0.1ml; AIV H9 ≥ 10^7.4EID₅₀ /0.2 ml.

[Indication]

It is used to prevent NDV and Avian Influenza virus (subtype H9) infection in chickens.The immunity period is 6 months.

[Properties]  Milky white emulsion

[Dosage & Administration] 

Subcutaneous back of the neck or imtramuscular injection.

0.25 ml/bird subcutaneous injection in the neck for chickens within 4 weeks; 0.5 ml/bird intramuscular injection for chickens over 4 weeks, and the immunity period is 6 months.

[Storage & Shelf life] 2~8℃, valid for 24 months

[Specification] 250ml/bottle  500ml/bottle

[Reg No.] SYSZ190912235